Genesis Biopharma, Inc. Issues Letter to Shareholders  
8/8/2013 10:25:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, issued the following Letter to Shareholders today:

Help employers find you! Check out all the jobs and post your resume.